| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $8.45B+15.2% | $7.33B-6.3% | $7.83B-8.3% | $8.53B |
| Cost of sales (excluding depreciation and amortization) | -$7.26B-13.5% | -$6.40B+5.5% | -$6.77B+10.5% | -$7.57B |
| Depreciation and amortization | -$330.0M-8.6% | -$304.0M-1.3% | -$300.0M-3.4% | -$290.0M |
| Selling and administrative expenses | -$332.0M-6.1% | -$313.0M+1.3% | -$317.0M-11.6% | -$284.0M |
| Research and development expenses | -$51.0M-4.1% | -$49.0M+5.8% | -$52.0M-13.0% | -$46.0M |
| Other gains and losses – net | $43.0M+265.4% | -$26.0M+39.5% | -$43.0M+52.2% | -$90.0M |
| Finance costs – net | -$109.0M+1.8% | -$111.0M+0.0% | -$111.0M-7.8% | -$103.0M |
| Income before tax | $408.0M+202.2% | $135.0M-41.8% | $232.0M+54.7% | $150.0M |
| Income tax expense | -$133.0M-77.3% | -$75.0M+0.0% | -$75.0M-145.5% | $165.0M |
| Net income | $275.0M+358.3% | $60.0M-61.8% | $157.0M-50.2% | $315.0M |
| Equity holders of Constellium | $273.0M+387.5% | $56.0M-63.2% | $152.0M-50.6% | $308.0M |
| Non-controlling interests | $2.0M-50.0% | $4.0M-20.0% | $5.0M-28.6% | $7.0M |
| Basic (in USD per share) | $1950000.00+413.2% | $380000.00-63.5% | $1040000.00-51.4% | $2140000.00 |
| Diluted (in USD per share) | $1920000.00+405.3% | $380000.00-63.1% | $1030000.00-51.0% | $2100000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.